A5111162463- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- T-cell and Retrovirus Studies
- Digital Transformation in Industry
- Evaluation and Optimization Models
- CAR-T cell therapy research
- Collaboration in agile enterprises
Guizhou Cancer Hospital
2023-2024
Relapsed and/or refractory peripheral T-cell lymphoma (r/r PTCL) is an aggressive and heterogeneous hematologic malignancy with high unmet need. Previously, PI3K inhibitors were shown to be efficacious in B- lymphomas, but as a drug class, these agents have frequently been observed tolerability limitations. Next-generation that improve the while maintaining efficacy are desirable.
<div>AbstractPurpose:<p>Relapsed and/or refractory peripheral T-cell lymphoma (r/r PTCL) is an aggressive and heterogeneous hematologic malignancy with high unmet need. Previously, PI3K inhibitors were shown to be efficacious in B- lymphomas, but as a drug class, these agents have frequently been observed tolerability limitations. Next-generation that improve the while maintaining efficacy are desirable.</p>Patients Methods:<p>A phase Ib clinical study was conducted...
<p>Figure and Tables</p>
Medical examinations are an important part of a patient's hospital visit process. The long waiting time for examination and the uncertainty will cause patients to question service management level hospital, which lead decline in overall satisfaction with medical treatment. By discussing patient- centered appointment process, We established fully intelligent stakeholder value network based on stream clinical, technology, information, as relevant stakeholders, optimized reorganized original...